Which Plant Is Muira Puama? An Identity Problem

Most herb pages start with what a plant does. This one has to start with a harder question: which plant is it? "Muira puama" and "potency wood" are trade names, not botanical names, and they have been applied to more than one Amazonian species over more than a century of commerce. The material that reaches a jar is chipped or powdered bark and root-wood — the single hardest kind of botanical material to identify by eye — travelling through a wild-harvest supply chain with very little authentication anywhere along it.

That is not a footnote to the rest of this Benefits leg. It is the foundation of it. Every claim about muira puama's effect on libido, energy, mood or memory is a claim about a specific plant producing a specific chemistry, and if the plant behind the label is uncertain then the claim inherits that uncertainty whether the seller mentions it or not. So this page does the unglamorous work first: it lays out which names are in play, what is actually traded, why the usual quality signals cannot resolve it, and what an honest reader should conclude. The conclusion is uncomfortable in a way worth stating up front — an identity problem does not exonerate any plant. It indicts the product.

Table of Contents

1. The Short Answer
2. Three Botanical Names, One Trade Name
3. Liriosma ovata and the Older Literature
4. What Actually Gets Traded
5. Why Woody Material Is the Hardest Case
6. Why "Standardised To" Cannot Fix This
7. The Inversion: Who an Identity Problem Actually Convicts
8. What It Does to the Research Literature
9. How Identity Would Actually Be Established
10. Does the Name Itself Mislead?
11. What This Page Is Not Claiming
12. What a Buyer Can Actually Do
13. Numbered Findings: What Is Not Known
14. Key Research Papers
15. External Resources
16. Connections

The Short Answer

The species most often intended by "muira puama" is Ptychopetalum olacoides Bentham, a shrub or small tree of the Amazon basin. That is the plant named in nearly all of the modern pharmacology, and if a bottle names any species at all, this is usually the one it names.

But it is not the only plant sold under the name. Ptychopetalum uncinatum Anselmino circulates in the same trade and under the same common names. And Liriosma ovata appears throughout the older pharmacy and materia medica literature as the botanical identity of muira puama — either as a synonym for the same article or as a name for an adjacent one, depending on which source you read. Brazilian usage adds marapuama and muirapuama as spellings, and regional vernacular in the Amazon attaches "muira puama" to still other woody plants that share the reputation without sharing the genus.

So the honest answer to "which plant is muira puama?" is: usually P. olacoides, sometimes P. uncinatum, historically catalogued as Liriosma ovata, and in a powdered commercial sample, frequently unverifiable. Everything else on this page is an elaboration of that sentence and of why it matters more than it sounds.

Back to Table of Contents

Three Botanical Names, One Trade Name

It helps to see the three names as answering three different questions.

• Ptychopetalum olacoides Bentham answers what did the researchers study? The Brazilian pharmacology programme that produced almost the entire modern literature — the anticholinesterase work, the memory and anti-stress work, the neuroprotection work — consistently identifies its material as P. olacoides and typically as an ethanol extract of the root or bark. When this site reports a preclinical finding on the fatigue, mood and memory page, this is the plant behind it.
• Ptychopetalum uncinatum Anselmino answers what else is in the trade? It is a congener — same genus, same family (Olacaceae in the traditional circumscription), overlapping range, woody parts used the same way. Herbal reference works have noted for decades that both species are sold as muira puama. A congener is the most awkward possible substitute, because it is close enough to share much of the chemistry and therefore close enough to pass any test that looks only at chemistry.
• Liriosma ovata answers what did the old books call it? Late nineteenth and early twentieth century European and American pharmacy literature, the era in which muira puama first crossed the Atlantic as a commercial drug, frequently gave Liriosma ovata as its botanical source. That name is the reason older references, and any modern page that quietly copied from them, can appear to be describing a different plant from the modern papers.

Two of those three names are still in commerce, and the third is embedded in the historical record that the marketing draws on. No part of the supply chain reliably distinguishes them at the point of sale.

Back to Table of Contents

Liriosma ovata and the Older Literature

Liriosma is a real genus name in the Olacaceae grouping, and the taxonomic relationship between Liriosma and Ptychopetalum has been revised over the years in ways that are ordinary botanical business but unhelpful commercially. Two possibilities are consistent with what is documented, and the literature does not cleanly settle between them:

1. Liriosma ovata was an older name for the plant now called P. olacoides, in which case the historical drug and the modern drug are the same and nothing is lost.
2. Liriosma ovata named a genuinely different, adjacent plant that was traded under the same vernacular label, in which case the nineteenth-century clinical impressions that built muira puama's reputation may have been made on material other than the species the modern laboratories studied.

We are not going to pretend to resolve that here. Nomenclatural synonymy is a question for a monographer with type specimens, and asserting a confident answer from secondary sources is exactly the kind of guess this site refuses to make. What matters for a reader is the consequence, which is the same either way: the historical evidence and the modern evidence are not certainly about the same plant, and any page that treats a nineteenth-century tonic reputation as continuous with a 2003 rodent study is assuming a taxonomic identity it has not checked.

If you want to check a current accepted name yourself, the standard free reference is Kew's Plants of the World Online, with World Flora Online as a second opinion. Both will tell you which names are currently accepted and which are treated as synonyms — but note carefully what that does and does not buy you. It resolves the names. It says nothing whatever about which plant is in the jar on your shelf.

Back to Table of Contents

What Actually Gets Traded

The commercial article is bark and root-wood — sometimes stem-wood, sometimes a mixture, occasionally described only as "root" with no further detail. It leaves the forest as chips or short billets and reaches the consumer market as one of four things:

• Chipped bark or wood, for decoction. This is the form in which some morphological identification is at least conceivable, because bark surface features, fracture and structure survive chipping to a degree.
• Coarse or fine powder, usually destined for capsules. Here every gross morphological feature is gone. A powder of woody Amazonian bark looks, smells and feels much like other powders of woody Amazonian bark.
• Hydroalcoholic tincture or fluid extract, in which even the microscopic anatomy is gone and only chemistry remains.
• A component of a multi-ingredient formula, where the muira puama fraction is a line on a proprietary-blend label with no stated weight. This is the most common form of all, and it is the form the libido claims page has to spend most of its time on.

Layer onto that the fact that the raw material is overwhelmingly wild-harvested rather than cultivated. Wild harvest means a collector, often paid by weight, working in a forest that contains many woody plants and at least two Ptychopetalum species. It means aggregation through intermediaries, so that a single sack may not have a single botanical origin. And it means that the person who could have identified the standing plant — the collector, looking at leaves, flowers and habit — is several transactions removed from anyone who will ever ask.

Back to Table of Contents

Why Woody Material Is the Hardest Case

Authenticating a herb usually leans on a hierarchy of methods, and woody bark defeats them in order.

1. Whole-plant morphology is the gold standard and is unavailable by definition — nobody ships the tree.
2. Macroscopic examination of the drug works reasonably well for a leaf, a flower or a whole root, all of which retain diagnostic shape. Bark chips retain far less, and two congeneric barks may be macroscopically indistinguishable even to an experienced pharmacognosist.
3. Microscopy of powdered material is a genuine skill and a genuine tool, and for a well-characterised drug with a published anatomical description it can be decisive. For muira puama it is weakened twice: powdered woody tissue offers fewer diagnostic cell types than powdered leaf, and the comparative anatomy needed to separate P. olacoides from P. uncinatum in powder is not something a supplement buyer can look up.
4. Organoleptic checks — taste, smell, fracture — are what the traditional trade actually relied on. They are better than nothing and are hopeless against a congener.

There is a second, quieter problem. Even if the species is right, the plant part may not be what the label says, and part substitution is one of the standard ways a herbal claim goes wrong. A root result cited for a bark preparation is a different intervention, exactly as an extract result cited for a tea is. Muira puama's own literature is not always explicit about which woody part was extracted, and commercial material is frequently described as "bark and root" as if the two were interchangeable. They may be. Nobody has demonstrated that they are.

Back to Table of Contents

Why "Standardised To" Cannot Fix This

This is the single most important technical point on the page, and it is the one most often got backwards.

A marker-compound assay — "standardised to X% beta-sitosterol", "assayed for total sterols", "HPLC-verified" — is a potency check, not an identity check. It tells you how much of a chosen compound is present in the material you sent to the laboratory. It cannot tell you which plant the material came from unless the marker compound occurs in that plant and in essentially nothing else you might plausibly have been sold.

Muira puama fails that condition comprehensively, and it fails it worst for exactly the compounds most likely to appear on a certificate of analysis:

• Beta-sitosterol and campesterol are among the most widely distributed sterols in the plant kingdom. They occur in a very large fraction of all plants, edible and otherwise. A sample assaying positive for beta-sitosterol has told you it is made of plant material. That is all.
• Long-chain fatty acids and their esters are similarly generic in woody tissue.
• Coumarin is present in many unrelated plants, several of which are cheaper than Amazonian bark.
• The diterpene ptychonal, which is genuinely interesting and much more specific, is the one candidate marker with real diagnostic promise — and its distribution across Ptychopetalum species is not something a buyer can check, no routine commercial assay looks for it, and if it turns out to occur in P. uncinatum too then it cannot separate the two congeners either.

The general rule this illustrates is worth carrying to every other herb: where two candidate plants share the marker, "standardised to X" says nothing about identity. Only sequence-based methods — DNA barcoding of an appropriate region — discriminate between species that share their chemistry. A certificate of analysis reporting a marker in a genus with a commercially traded congener is a document that looks like verification and is not one.

This is why an unverified product stays unverified even when it arrives with paperwork, and it is why the phrase "third-party tested" needs a follow-up question: tested for what? Heavy metals and microbial limits are worth having and are not identity. Identity is a separate test that almost nothing on this shelf has had.

Back to Table of Contents

The Inversion: Who an Identity Problem Actually Convicts

There is a standard move in herbal writing that runs like this: a herb was blamed for a harm, later analysis suggested the implicated material was a different, substituted species, therefore the herb is exonerated. The move is often factually correct about the substitution, and it is almost always deployed in the wrong direction.

Apply it honestly to muira puama and it inverts:

• The reattribution clears a plant. It does not clear a bottle. If the species behind an effect — good or bad — is uncertain, then the plant identified as innocent is a botanical abstraction, while the product on the shelf is the thing you swallow. The abstraction's innocence transfers to your capsule only if your capsule contains it, which is the very thing in question.
• Uncertainty is not neutral; it is asymmetric. If you cannot tell which plant you bought, the reasonable inference is not "probably the good one." It is "the safety and efficacy record of P. olacoides may not apply to this material at all." A century of apparently uneventful traditional use of one plant is not reassurance about a powder that may be a congener, an adjacent species, or an adulterated blend.
• The strongest argument against unverified loose material is the exculpation itself. Every time someone explains an anomalous result by saying "that batch was probably misidentified," they are conceding that misidentification happens in this trade at a rate high enough to be the default explanation for anomalies. That concession is much more damaging to the product category than the original anomaly was.

Two other herbs on this site illustrate the same logic from the opposite end, and it is worth seeing that muira puama is not being singled out. Epimedium is traded as a genus with many species of differing chemistry, and its product-quality page reaches the same conclusion by the same route. Tongkat Ali has the additional problem of a famous name attached to material that is often not the plant at all. The pattern is a property of the botanical libido shelf, not of one plant.

Back to Table of Contents

What It Does to the Research Literature

An identity problem is not only a consumer problem. It propagates into the evidence base in three specific ways, and knowing them changes how you read a citation.

1. Voucher specimens are the fix, and they are invisible to readers. Good ethnopharmacology deposits a voucher — a pressed, catalogued specimen in a named herbarium — so that a later worker can check what was actually extracted. The Brazilian group behind most of the muira puama pharmacology worked in the tradition that does this, and their papers name P. olacoides specifically. That is a real point in their favour and it is why this Benefits leg treats their findings as findings about a known plant. But a reader who encounters the result second-hand, in a supplement blog or a marketing page, has no way to know whether the underlying paper vouchered its material or bought a bag of powder.

2. Negative and inconsistent results become uninterpretable. When two laboratories disagree about a woody herb with a congener in trade, there are now at least three explanations rather than one: real biological variability, methodological difference, or different plants. That third possibility is rarely testable after the fact, and it makes an already thin literature harder to synthesise.

3. Citation drift carries the ambiguity forward while stripping the caveat. A paper says "ethanol extract of Ptychopetalum olacoides bark, voucher deposited." A review says "muira puama extract." A marketing page says "muira puama." A shopper reads "muira puama" and buys a powder of unknown species. Nothing false was said at any step, and the specificity that made the original claim meaningful evaporated in three moves. This is the reason the pages in this leg label the provenance of a finding at the finding rather than once in a preamble — a reader who arrives mid-page, or who lifts a single sentence, should not be able to carry away an unlabelled version.

Back to Table of Contents

How Identity Would Actually Be Established

It is easy to describe a problem and leave the reader with nothing but doubt. The more useful move is to say precisely what would settle it — because the tools exist, they are neither exotic nor expensive, and the reason they have not been applied here is that nobody has chosen to pay for it.

1. DNA barcoding of the plastid and nuclear regions used for plant identification — rbcL and matK as the standard plant barcodes, with the nuclear ribosomal ITS2 region often added because it discriminates better between close congeners. A reference sequence library for P. olacoides and P. uncinatum from vouchered material is the prerequisite, and building one is a modest project, not a moonshot.
2. Next-generation sequencing metabarcoding for mixed and multi-ingredient products, which can report every plant genus present in a capsule rather than confirming or denying one. This is the method that has repeatedly found declared ingredients missing and undeclared ones present across the wider supplement market.
3. Published comparative microscopy of the powdered bark and root-wood of both traded species, so that a competent analyst without a sequencer has something to compare against.
4. A pharmacopoeial monograph with an identity test, not merely a purity and potency test. A monograph is what converts all of the above from a research finding into a routine quality gate.
5. Chemometric fingerprinting — a full chromatographic profile compared against vouchered reference material, rather than a single marker peak. Weaker than sequencing for identity, but far stronger than a one-compound assay, and achievable with equipment a contract laboratory already owns.

None of these has been systematically applied to the commercial muira puama supply that we can find published. That is the finding. It is not that the plant failed a test; it is that the test has not been run, and the difference between those two statements is one this whole Benefits leg is built on.

Back to Table of Contents

Does the Name Itself Mislead?

Some common names smuggle in an implication the plant does not earn, and it is worth checking directly rather than assuming. Here the check comes back mostly clear, with one narrow exception, and reporting a clear result is as much a part of accuracy as reporting a bad one.

• "Potency wood" and muira puama make a claim about effect, not about safety. The name promises that the wood does something. It does not imply the plant is gentle, food-like, suitable in pregnancy, or free of interactions — the way that, say, a name containing "mother" can quietly imply obstetric safety in a plant that is actually contraindicated. Nobody is misled about safety by the word "potency."
• The narrow exception is the reverse inference. A name that asserts potency invites the assumption that the material is pharmacologically active, and therefore that a small dose is meaningful and a large one risky. In fact the active principle is not established at all (see the dose and safety page), so the name overstates how much is known about the chemistry in the direction of activity.
• The genuinely misleading part of the label is not the common name but the absence of a botanical one. "Muira puama" on a jar is a marketing term doing the work of a species name. A product that printed "Ptychopetalum olacoides, root bark" would be making a checkable statement. Most do not.

Back to Table of Contents

What This Page Is Not Claiming

Refusing to overstate runs in both directions, and it would be easy to read this page as darker than it is. Several things are not being alleged, and a reader arriving from other herb pages may reasonably wonder about each.

• This is not a toxic-substitution story. There is no documented pattern of muira puama being adulterated with a poisonous plant, in the way that germander was substituted for skullcap with real hepatotoxic consequences. What is documented is species ambiguity within a genus, which degrades the reliability of the claims rather than creating a known poisoning hazard.
• No pyrrolizidine-alkaloid problem is being alleged. Muira puama is not in a family associated with hepatotoxic pyrrolizidine alkaloids, and nothing here should be read across from comfrey, coltsfoot or borage.
• P. uncinatum is not being called dangerous. It may well be pharmacologically similar to P. olacoides; that is precisely why it is a plausible substitute. The objection is that similarity is being assumed rather than demonstrated, not that the congener is known to be harmful.
• The Brazilian pharmacology is not being dismissed. It is careful work on named, vouchered material and the fatigue and mood page reports it as such. The gap is between that material and commercial material, not inside the papers.
• No duration cap is being proposed on identity grounds. Some herbs carry a hard time limit because the active moiety is itself the hazard. Nothing about muira puama's identity problem implies that; the caution it implies is about trust in the label, not about cumulative exposure.

The single concrete adulteration hazard on this shelf is a different one entirely — undeclared prescription erectile-dysfunction drugs in sexual-enhancement supplements — and it is dealt with in detail on the dose and safety page, because it is a category risk rather than a botany problem.

Back to Table of Contents

What a Buyer Can Actually Do

Given all of the above, the practical advice is narrower than most sites offer, and deliberately so. Nothing below promises you the right plant. Each item shifts the odds, and it is worth being clear which do more work than others.

1. Insist on a binomial and a plant part on the label. "Ptychopetalum olacoides root bark" is a checkable claim; "muira puama extract" is not. This is the highest-value single filter, not because the label is verified but because a company willing to commit to a species in print has taken on a liability that a company printing a trade name has avoided.
2. Prefer chipped bark or wood over powder if you are buying raw material, since it is the only form in which any morphological check is possible at all.
3. Read a certificate of analysis for what it actually tests. Heavy metals, microbial limits and a marker assay are all worth having. None of them is an identity test. If the certificate does not name a species-level identity method, treat identity as unestablished.
4. Treat proprietary blends as unquantified. A blend that does not state the muira puama weight has told you nothing about dose, and a blend is also where undeclared pharmaceuticals have historically turned up in this category.
5. Do not let independent certification carry more than it can. Programmes such as USP and NSF verification are genuinely valuable for contamination and label-quantity accuracy, and they operate on very few products in this niche. Their presence is a good sign; their absence is the normal case.
6. Ask the vendor directly whether the species identity was confirmed and how. The answer is informative either way, including when there is no answer.

Back to Table of Contents

Numbered Findings: What Is Not Known

The following are stated as results, not as gaps for the reader to infer. Each is a thing that could be known and is not.

1. The proportion of commercial "muira puama" that is P. olacoides is unknown. No published market survey using species-level identification has been located.
2. Whether P. uncinatum is pharmacologically equivalent is unknown. It has not been studied alongside P. olacoides in the same model at the same dose.
3. The correct nomenclatural status of Liriosma ovata relative to Ptychopetalum is not resolved here and asserting one would be a guess. Consequently the continuity between the historical drug and the modern one is unestablished.
4. No validated marker exists that discriminates the traded species. The commonly assayed constituents are pan-plant compounds.
5. No reference DNA barcode library for the traded Ptychopetalum species is publicly available so far as we can determine, which means even a willing laboratory has nothing authoritative to match against.
6. Bark, root-bark and stem-wood have not been compared for constituent profile or activity, so part substitution cannot be assessed.
7. Wild-harvest chain of custody is undocumented in the published literature, including the number of intermediaries and whether sacks are aggregated across collectors.
8. No pharmacopoeial identity monograph with a species-discriminating test has been located for muira puama.
9. The sustainability position is also unquantified. The article is wild-harvested bark and root-wood from a slow-growing woody plant, which is the harvest pattern most likely to be destructive, and no population assessment has been located. That is a real unknown and it is being flagged rather than either alarmed about or waved away.

Back to Table of Contents

Key Research Papers

Every citation below links a PubMed topic search rather than a fixed record, so that you see the current literature on the question rather than one paper chosen for you. Where metadata could not be verified with confidence, that is stated explicitly rather than papered over.

1. Siqueira IR and colleagues. "Ptychopetalum olacoides, a traditional Amazonian 'nerve tonic', possesses anticholinesterase activity." Pharmacology, Biochemistry and Behavior, 2003. Find on PubMed — cited here for its identification practice rather than its result: the material is named to species and characterised as an ethanol extract, which is what makes the finding attributable to a known plant.
2. Bucek EU, Fournier G, Dadoun H. "Volatile constituents of Ptychopetalum olacoides root oil." Planta Medica, 1987. Find on PubMed — an early analysis of the aromatic fraction of the root. Relevant to identity because a volatile profile is a candidate fingerprint, and because it is explicitly a root analysis in a trade that sells bark, root and stem interchangeably.
3. Chemistry of Ptychopetalum diterpenoids, including ptychonal. PubMed topic search — the diterpene series is the most structurally distinctive chemistry reported from the genus and therefore the most promising candidate for a genuine identity marker. We have deliberately not attached specific author or journal metadata to this entry: the primary reports are hard to verify from secondary sources, and a confident citation here would be a guess.
4. Ptychopetalum species and their distribution in trade. PubMed topic search — the congener is thinly represented in the indexed literature, which is itself the point. A plant sold under the same name as a much-studied relative, with almost no literature of its own, is the definition of an unverifiable substitution.
5. DNA barcoding for herbal identification. PubMed topic search — the methodological literature that establishes ITS2, rbcL and matK as workable identity tools for commercial botanicals. Read this to see how routine the technique now is, which is what makes its absence here a choice rather than a limitation.
6. Metabarcoding surveys of commercial herbal products. PubMed topic search — the body of work that repeatedly finds declared species absent and undeclared species present across supplement markets. None of it is specific to muira puama; all of it is the base rate against which an unverified Amazonian bark powder should be judged.
7. Marker-compound standardisation and its limits. PubMed topic search — the pharmacognosy literature distinguishing potency assays from identity tests, which is the technical basis for this page's central argument.
8. Beta-sitosterol distribution across plants. PubMed topic search — sufficient to show why a beta-sitosterol assay identifies "plant" and not "this plant."
9. Amazonian medicinal bark harvest and sustainability. PubMed topic search — general literature on the harvest pattern muira puama belongs to; no population assessment specific to Ptychopetalum was located.
10. Pharmacognostic authentication of powdered bark drugs. PubMed topic search — the methods literature behind the claim that powdered woody material is the hardest case for microscopy.

Back to Table of Contents

External Resources

• Plants of the World Online — Kew's accepted-name database; the right place to check current nomenclature for Ptychopetalum and Liriosma.
• World Flora Online — a second taxonomic opinion, useful when synonymy is contested.
• PubMed — the index behind every topic search on this page.
• National Center for Complementary and Integrative Health — plain-language summaries of what is and is not established for botanicals.
• United States Pharmacopeia and NSF — the two best-known independent supplement verification programmes.

Back to Table of Contents

Connections

• All Herbs
• Muira Puama — main article
• Muira Puama Benefits — hub
• Muira Puama for Libido: Examining the Claims
• Muira Puama for Fatigue, Mood and Memory
• Muira Puama: Dose, Formulations and Safety
• Epimedium: Safety, Adulteration and Product Quality
• Tongkat Ali: Product Quality and Adulteration
• Tribulus: Saponins, Quality and Safety
• Damiana: Aphrodisiac Claims Examined
• Damiana
• Maca
• Tribulus
• Epimedium
• Tongkat Ali
• Ginseng
• Ginkgo Biloba

Back to Table of Contents